Home/ Stocks/ SANA

Sana Biotechnology, Inc. Common Stock

SANA XNAS

$3.51 +0.00 (+0.05%) ▲ 15-min delayed

Open

$3.45

High

$3.58

Low

$3.44

Volume

1.64M

Market Cap

$947.67M

About Sana Biotechnology, Inc. Common Stock

Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates comprises SC291, SC262, UP421, and others.

Sector: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Employees: 142 Website →

Key Financials

Period	Revenue	Net Income	EPS
TTM 2025	$0	$-244,166,000	$-0.96
FY 2025	$0	$-244,166,000	$-0.96
Q3 2025	$0	$-42,152,000	$-0.16
Q2 2025	$0	$-93,800,000	$-0.39

Related Market News

No specific coverage for SANA yet. Check out our latest market news or earnings calendar.

Get SANA Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Sana Biotechnology, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.